The Gut-Joint Axis: Insights into the Microbiome’s Role in Aching Joints.

The intricate relationship between the gut microbiome and joint pain has emerged as a critical area of study in autoimmune and degenerative joint diseases. Emerging evidence highlights the gut-joint axis, a bidirectional communication system where gut microbiota composition directly influences systemic inflammation and joint health through immune modulation, metabolic signaling, and neural pathways.

Linking Gut Dysbiosis to Joint Pathology

Gut dysbiosis disrupts immune homeostasis by altering the balance of pro-inflammatory and anti-inflammatory cytokines. It does this through immune system activation. Let's take a step back and chat about how this is possible! When people think about the gut, the small intestine, and the large intestine, they don't think about the immune system being there. 70% of it is located in gut-associated lymphoid tissue (GALT). Let me show you a picture, and then we can discuss more below.

Tourkochristou E, Triantos C, Mouzaki A. The Influence of Nutritional Factors on Immunological Outcomes. Front Immunol. 2021 May 31;12:665968.

The above photo is a snapshot of the immune "surveillance" system that is mostly in the last portion of the small intestine, right before it becomes the large intestine. Look for the word GALT. This is the gut-associated lymphoid tissue I mentioned before the photo. The GALT was designed perfectly to surveil for antigens that may pose a harm to the "human". However, this protection may become manipulated and overstimulated by the toxins in our food, the quality of our food, and, as a result, the bacteria that are present in the gut microbiome. When the imbalance of health-promoting bacteria happens in the gut microbiome, we call this Dysbiosis. A dysbiotic microbiome leads to the proinflammatory response and therefore poses a full-body effect. Think about the above photo and our gut microbiome as two sides of a conversation; the metabolites made by bacteria "converse" with these pockets of immune tissue about the state of the ecosystem. Let's discuss some examples.

Faecalibacterium prausnitzii, a beneficial bacterium, suppresses IL-17 production and promotes regulatory T-cell (Treg) activity, reducing joint inflammation. Without getting into the weeds of immunology, just observe the protective effect of having the "good guys" around. Conversely, dysbiosis increases Streptococcus species, which release pro-inflammatory microvesicles linked to osteoarthritis (OA)-related knee pain.

Dysbiosis, as we have discussed in previous posts, and I know many of my clients and I have discussed in depth, leads to a condition of "leaky gut," which allows bacterial lipopolysaccharides (LPS) and other metabolites to enter circulation. LPS activates macrophages (an immune cell) in synovial joints, exacerbating cartilage degradation and pain. This mechanism is implicated in rheumatoid arthritis (RA), where dysbiosis precedes clinical symptoms. The dysbiosis comes first! So, if we can manage this dysbiosis, we can manage the downstream impact, long-term pain, and destruction of the joints. Similarly, gut-derived metabolites such as trimethylamine N-oxide (TMAO) promote OA progression by enhancing the aging and deterioration of cartilage cells!

Let's summarize

Pro-inflammatory taxa: Streptococcus spp., Proteobacteria, and Actinobacteriota correlate with elevated joint pain and radiographic severity.

Protective taxa: Bifidobacterium and Lactobacillus species mitigate inflammation by restoring gut barrier integrity and producing anti-inflammatory SCFAs.

Dietary Interventions

High-fiber, Mediterranean-style diets reduce dysbiosis and LPS translocation, lowering systemic inflammation.

Elimination of gluten and dairy improves symptoms in susceptible individuals by reducing immune activation.

Microbiota-Targeted Therapies

Probiotics (e.g., Lactobacillus casei) show promise in restoring microbial balance and attenuating RA progression. Prebiotics like inulin enhance Faecalibacterium prausnitzii abundance, suppressing IL-17-driven joint damage.

Megasporebiotic from Microbiome Labs is my number one recommended probiotic supplement due to its quality and strain-specific formulation that survives stomach acid and makes its way to the gut due to its incredible spore-protected mechanism.

MegaPre from Microbiome Labs is a beautiful formulation of prebiotic fiber that houses that incredible bacterial buffet blend of Xylooligosaccharides (XOS), Galacto-oligosaccharides (GOS), and Fructooligosaccharides (FOS). You know how you are what you eat? Well, the same goes for microbes, literally.

Whole-genome sequencing is the top-of-the-line methodology in understanding gut architecture and dysbiotic ratios in the gut microbiome. If you would like to test your gut and better understand how your gut microbiome might predispose you to inflammation, autoimmunity, and metabolic disease, don't hesitate to reach out. You can find me at Brain and Body Rehabilitation in Roswell, Ga. Just ask for the "gut girl," AKA Melody, and I'll have your back...and your gut!

References:

1. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol. 2011;7(10):569-578. doi:10.1038/nrrheum.2011.121

2. Rogier R, Evans-Marin H, Manasson J, et al. Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and humans. Arthritis Rheumatol. 2017;69(5):857-868. doi:10.1002/art.40090

3. Boer CG, Hatzikotoulas K, Southam L, et al. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations. Cell. 2021;184(18):4784-4818.e17. doi:10.1016/j.cell.2021.07.019

4. Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895-905. doi:10.1038/nm.3914

5. Jhun J, Min HK, Na HS, et al. Commensal microbiota are associated with susceptibility to experimentally induced arthritis in mice. J Transl Med. 2016;14:36. doi:10.1186/s12967-016-0784-6

6. Chen J, Wright K, Davis JM, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8(1):43. doi:10.1186/s13073-016-0299-7

7. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57-63. doi:10.1038/nature09922

8. Zhuang Z, Yang R, Wang W, et al. Gut microbiota-mediated inflammation in obesity: A potential therapeutic target for metabolic syndrome. Front Immunol. 2019;10:2987. doi:10.3389/fimmu.2019.02987

9. Manasson J, Blank RB. The microbiome in rheumatology: Where are we and where should we go? Ann Rheum Dis. 2021;80(7):771-779. doi:10.1136/annrheumdis-2020-218743

10. Alwarith J, Kahleova H, Rembert E, et al. The role of nutrition in rheumatoid arthritis: Plant-based diets as a therapeutic strategy. Am J Lifestyle Med. 2019;13(4):322-332. doi:10.1177/1559827619826127

11. Van Kruiningen HJ, West AB, Freda BJ, Holmes KA. Distribution of Peyer's Patches in the Distal Ileum. Inflamm Bowel Dis. 2002;8(3):180-185. doi:10.1097/00054725-200205000-00004.

12. Jung C, Hugot JP, Barreau F. Peyer's Patches: The Immune Sensors of the Intestine. Clin Dev Immunol. 2010;2010:823710. doi:10.4061/2010/823710.

13. Seladi-Schulman J. Peyer's Patches: Definition, Location, Function, Related Conditions. Healthline. April 13, 2018.

14. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol. 2004;25(11):570-577. doi:10.1016/j.it.2004.08.007

15. Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14(10):667-685. doi:10.1038/nri3738

16. Macpherson AJ, Geuking MB, McCoy KD. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology. 2005;115(2):153-162. doi:10.1111/j.1365-2567.2005.02159.x

17. Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity. 2008;28(6):740-750. doi:10.1016/j.immuni.2008.05.001

18. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313-323. doi:10.1038/nri2515

19. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268-1273. doi:10.1126/science.1223490

20. Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539-544. doi:10.1126/science.aad9378

21. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-141. doi:10.1016/j.cell.2014.03.011

22. Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016;14(1):20-32. doi:10.1038/nrmicro3552

23. Knoop KA, Newberry RD. Goblet cells: multifaceted players in immunity at mucosal surfaces. Mucosal Immunol. 2018;11(6):1551-1557. doi:10.1038/s41385-018-0061-0